Antidepressants and Colorectal Cancer Risk
Author Information
Author(s): Cronin-Fenton D P, Riis A H, Lash T L, Dalton S O, Friis S, Robertson D, Sørensen H T
Primary Institution: Department of Clinical Epidemiology, Aarhus University Hospital
Hypothesis
Does the use of antidepressants reduce the risk of colorectal cancer?
Conclusion
The study found no evidence that antidepressant use substantially reduces the risk of colorectal cancer.
Supporting Evidence
- Previous studies suggested SSRIs might reduce CRC risk, but this study found no significant association.
- The study included 9979 cases and 99,790 controls matched on sex, birth year, and residence.
- Odds ratios for antidepressant use were near null, indicating no protective effect against CRC.
- Non-differential misclassification of antidepressant use was a noted limitation.
- Findings align with other studies that also reported no significant reduction in CRC risk with antidepressant use.
Takeaway
The study looked at whether taking antidepressants helps prevent colorectal cancer, but it found that they don't really make a difference.
Methodology
A population-based case–control study was conducted using prescription data to investigate the association between antidepressant use and colorectal cancer risk.
Potential Biases
Potential confounding by indication, as severity of depression may affect antidepressant use and cancer risk.
Limitations
Non-differential misclassification of antidepressant use and inability to adjust for body mass index, physical activity, or diet.
Participant Demographics
The median age of participants was 72.4 years, with a balanced gender distribution.
Statistical Information
P-Value
0.94 for TCAs, 0.97 for SSRIs, 0.95 for other antidepressants
Confidence Interval
0.84, 1.05 for TCAs; 0.90, 1.05 for SSRIs; 0.83, 1.07 for other antidepressants
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website